Women's Cancer Center of Nevada

Recent papers from Women's Cancer Center of Nevada

1. TroFuse-032 study design: pembrolizumab plus sacituzumab tirumotecan or chemotherapy followed by pembrolizumab plus chemotherapy as neoadjuvant therapy for early-stage, triple-negative breast cancer or HR-low+/HER2− breast cancerFuture Oncology · 2026
2. Transforming Obstetric Care Through an MFM-Led Architectural System: A Proposed Model for High-Value Care Running Title: Transforming Obstetric Care: MFM architectureAmerican Journal of Perinatology · 2026
3. Virtual AI-informed immunocyte profiling (VAIP) from H&E as a predictor of multi-cancer prognosis.Journal of Clinical Oncology · 2026
4. Unilateral cervical carcinoma in a septate uterus with double cervix: A case report and literature reviewGynecologic Oncology Reports · 2026
5. Neonatal impact of maternal biomarker screening for risk of preterm birth with targeted interventions (PRIME): A multicenter, randomized, controlled trialPregnancy · 2026
6. A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG studyGynecologic Oncology · 2025
7. Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer PatientsClinical Cancer Research · 2025
8. A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer.Journal of Clinical Oncology · 2024
9. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and overThe Medicine Forum · 2024
10. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical TrialJournal of Clinical Oncology · 2024
11. Case report: abemaciclib-induced syndrome of inappropriate antidiuretic hormone (SIADH) without underlying kidney injury in a patient with early-stage estrogen receptor (ER)+ breast cancerFrontiers in Medicine · 2024
12. Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology StudyJournal of Clinical Oncology · 2022
13. Impact of Homologous Recombination Status and Responses With Veliparib Combined With First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 StudyObstetrical & Gynecological Survey · 2022
14. Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology TrialJournal of Clinical Oncology · 2022
15. Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 studyThe Medicine Forum · 2021
16. A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular ResponseClinical Cancer Research · 2021
17. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer SurvivalJNCI Journal of the National Cancer Institute · 2021
18. Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxaneCancer Research · 2021
19. Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival AnalysisClinical Cancer Research · 2020
20. An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275Gynecologic Oncology · 2020